Sequoia Capital China

  • DATABASE (1287)

  • ARTICLES (534)

    • DATABASE (1287)
    • ARTICLES (534)
  • Sort by
    • Relevance
    • Date

Kinzon Capital was co-founded by several former senior executives of Fosun Kinzon Capital (now called Fosun RZ Capital) in 2016. It invests primarily in early- and growth-stage TMT companies from China and the US. Kinzon Capital has offices in Beijing, Shanghai, Shenzhen and Silicon Valley and has invested RMB 2 billion in potential companies.

Sky9 Capital is founded by the former co-founder and managing director of Lightspeed China Partners, Cao Darong. As an early-stage venture capital firm, it focuses on investing in TMT (Technology, Media and Telecommunications), especially Internet innovation and enterprise services. The company has a strong presence in Beijing, Shanghai, Shenzhen and Silicon Valley in the US.

Bao holds two bachelor’s degrees in Finance and Communications Engineering from the Harbin Institute of Technology and a master’s degree in Financial Mathematics from the University of Chicago. He worked as an associate at Morgan Stanley's Global Capital Markets business unit from 2011 to 2015. Bao then worked as an investment associate at Chinese group buying website Meituan-Dianping from 2015 to 2016 and at Legend Capital from 2016 to 2017. In 2017, he co-founded Huajuan Mall and has since served as head of strategy.

One of the earliest and independent VC firms in China, Chengwei Capital was founded in Shanghai in 1999. It’s also the first and only evergreen fund in China.With Yale University Endowment as its largest investor, the VC limited partners also include institutional investors from around the world. With a portfolio of about 30 companies, the firm mainly invests in manufacturing, consumer goods, education, internet and petroleum & natural gas.In 2012, Chengwei and China Europe International Business School (CEIBS) jointly launched the $100m CEIBS-Chengwei Venture Capital Fund to invest in early- and growth-stage companies founded or managed by CEIBS alumni. The VC also seeks to support entrepreneurs to build sustainable businesses over a long period of time, acting as their long-term business partner. 

Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.

Established in 2010, Flourish Libra Venture Capital is a Fund of Funds (FOF) management firm and focuses on private equity in Greater China. It has invested some funds under Jiuding Capital, Fortune, NewMargin Ventures, Tiantu Capital, SAIF Partners, etc.

Toutoushidao Capital was co-founded in 2015 by Cao Guoxiong, partner of Matrix Partners China, and Wu Xiaobo, a well-known financial writer. Mainly targeting the culture and entertainment sectors, it had planned to invest RMB 2bn–RMB 3bn in the next three years.

Founded in 2016, Shanjin Capital is a PE fund manager approved by the Asset Management Association of China. With a focus on new energy and emerging technologies, the firm mainly invests in clean energy, connected vehicles, medtech and healthcare.

Hong Kong-based Jeneration Capital was founded in 2015 by Jimmy Chang, a former banker at Morgan Stanley. It now manages approximately US$2bn in capital, utilizing a multi-strategy investment approach with an emphasis on direct investment and dynamic asset allocation across private equity, public equity and diversified fund investments. In terms of direct investment, Jeneration Capital mainly invests in growth-stage technology-enabled companies in the Asia-Pacific region, with a focus on Greater China. 

Forebright Capital originates from the PE investment team established in 2001 under the state-owned China Everbright which is listed in Hong Kong. Everbright was spun off in May 2014 as an independent company. With money raised from institutional investors and family offices at home and abroad, Forebright Capital currently manages four US-dollar funds. It mainly invests in sectors of clean energy, healthcare and fintech.

China Renaissance offers private placement advisory, M&A advisory, securities underwriting, research, sales and trading, investment management and other financial services. It has clients in mainland China, Hong Kong and the United States as well as offices in Shanghai, Beijing, Hong Kong and New York. China Renaissance has facilitated more than 300 private financial transactions collectively valued at over US$20 billion.

Founded in 2015, iResearch Capital is an investment fund of iResearch Group, one of the first consulting companies on internet research and analytics in China.  It focuses on investment in marketing, big data, corporate services and new media companies.

Creadev was created in 2002 in France as the private equity arm of the Mulliez family. Creadev expanded to Shanghai in 2012, through a unit called Crehol China. It has since been renamed Creadev China.  

SkyDeck Berkeley is the startup accelerator initiated by the University of California, Berkeley. It was established to commercialize the university’s research arm and startup ventures of its alumni. It provides non-equity funding assistance, mentorship and networking opportunities, as well as specialist resources for not-for-profit ventures.Since 2012, SkyDeck-backed startups have raised total funding of over $1.47bn, with 17 achieving exits through acquisitions. The accelerator’s investment-arm is Berkeley SkyDeck Fund also invests about $100,000 per startup during the program. Half of the SkyDeck fund’s profits goes to UC Berkeley to support public education projects. The fund is run by Chon Tang as managing partner and Brian Bordley as principal. Contributors to the fund include private individuals, corporations and VCs like Sequoia Capital, Sierra Ventures and Canvas Ventures.

Healthcare-focused investment firm Vivo Capital was formed in 1996. Today it has over US$1.8 billion under management, making investments into private and public healthcare companies in the US and Greater China, as well as into promising early-stage innovative healthcare companies.

Sorry, we couldn’t find any matches for “Sequoia Capital China”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

Our Privacy and Cookies policies and our Terms of Use may have been updated since your last visit. By continuing to browse this website, you consent to our use of cookies, as well as to our Terms of Use and Privacy Policy, which provides additional information about how we process your data. This website uses cookies to enhance your user experience. Please read our Cookies Policy for more information on how we use cookies, as well as instructions on how to disable cookies. You may disable cookies through your internet browser settings, however this may result in some parts of the website not working properly for you.